In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects
Introduction One recent advance in the management of type 2 diabetes has been the development and clinical use of DPP-4 inhibitors and GLP-1 receptor agonists
The inclusion of semaglutide (brands include Ozempic, Rybelsus and Wegovy) in our medical weight loss programs extends a multitude of benefits, each contributing to a holistic and sustainable transformation
Without insurance, list prices in 2026 are roughly: Wegovy $1,349 per month, Zepbound $1,086 per month (auto-injector) or $349 to $549 (vials through LillyDirect), Ozempic $998 per month, Mounjaro $1,069 per month
FDA is aware of six adverse events from this lot, none of which are serious and are consistent with known common adverse reactions to authentic Ozempic, which are nausea, vomiting, diarrhea, abdominal pain, and constipation
Some studies show weight loss and small A1c improvements in certain people, often those with overweight or obesity, but nausea and tolerability are common issues